Merck (MRK) Tops Q2 EPS by 12c, Beats on Revenue; Offers FY24 EPS Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $119.60 +3.57%
EPS Growth %: -0.9%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of $2.28, $0.12 better than the analyst estimate of $2.16. Revenue for the quarter came in at $16.11 billion versus the consensus estimate of $15.85 billion.
GUIDANCE:
Merck sees FY2024 EPS of $7.94-$8.04, versus the consensus of $8.16. Merck sees FY2024 revenue of $63.4-64.4 billion, versus the consensus of $64.3 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Cboe launches binary options suite tied to Mini-S&P 500 Index
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
